DK123239B - Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-4,4-dialkylquinazoliner. - Google Patents

Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-4,4-dialkylquinazoliner.

Info

Publication number
DK123239B
DK123239B DK621469AA DK621469A DK123239B DK 123239 B DK123239 B DK 123239B DK 621469A A DK621469A A DK 621469AA DK 621469 A DK621469 A DK 621469A DK 123239 B DK123239 B DK 123239B
Authority
DK
Denmark
Prior art keywords
dialkylquinazolines
tetrahydro
preparation
analogous process
analogous
Prior art date
Application number
DK621469AA
Other languages
Danish (da)
English (en)
Inventor
G Suchowsky
L Bernardi
A Bonsignori
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Publication of DK123239B publication Critical patent/DK123239B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK621469AA 1968-11-26 1969-11-24 Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-4,4-dialkylquinazoliner. DK123239B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2416068 1968-11-26

Publications (1)

Publication Number Publication Date
DK123239B true DK123239B (da) 1972-05-29

Family

ID=11212294

Family Applications (1)

Application Number Title Priority Date Filing Date
DK621469AA DK123239B (da) 1968-11-26 1969-11-24 Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-4,4-dialkylquinazoliner.

Country Status (16)

Country Link
US (1) US3660322A (is")
AT (1) AT290542B (is")
BE (1) BE742205A (is")
BR (1) BR6914433D0 (is")
CH (1) CH523892A (is")
DE (1) DE1958515B2 (is")
DK (1) DK123239B (is")
ES (1) ES373909A1 (is")
FR (1) FR2024241B1 (is")
GB (1) GB1231959A (is")
IE (1) IE33406B1 (is")
IL (1) IL33393A (is")
NL (1) NL147140B (is")
NO (1) NO123430B (is")
SE (1) SE360659B (is")
YU (1) YU33286B (is")

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31617E (en) * 1972-02-04 1984-06-26 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
DE3815767A1 (de) * 1988-05-09 1989-11-23 Karl Niggemeier Abhefter fuer einzelblaetter
KR950701322A (ko) * 1992-05-07 1995-03-23 조셉 에프. 디프리마 사람면역결핍바이러스 역전사효소의 억제제로서의 신규한 퀴나졸린(New quinazolines as inhibitors of HIV reversetranscriptase)
US6124302A (en) * 1997-04-09 2000-09-26 Dupont Pharmaceuticals 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors
EP1068189A1 (en) * 1998-03-27 2001-01-17 Bristol-Myers Squibb Pharma Company 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors

Also Published As

Publication number Publication date
NL6917085A (is") 1970-05-28
IE33406L (en) 1970-05-26
DE1958515A1 (de) 1970-07-09
AT290542B (de) 1971-06-11
DE1958515B2 (de) 1976-06-24
SE360659B (is") 1973-10-01
ES373909A1 (es) 1972-08-16
CH523892A (de) 1972-06-15
BR6914433D0 (pt) 1973-02-22
BE742205A (is") 1970-05-25
YU33286B (en) 1976-08-31
IL33393A (en) 1973-04-30
FR2024241B1 (is") 1973-07-13
IL33393A0 (en) 1970-01-29
NL147140B (nl) 1975-09-15
YU292269A (en) 1976-03-31
IE33406B1 (en) 1974-06-12
NO123430B (is") 1971-11-15
US3660322A (en) 1972-05-02
FR2024241A1 (is") 1970-08-28
GB1231959A (is") 1971-05-12

Similar Documents

Publication Publication Date Title
DK132174B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider.
DK136421B (da) Analogifremgangsmåde til fremstilling af 1,4-dihydropyridin-derivater.
DK127113B (da) Analogifremgangsmåde til fremstilling af 1,4-dihydropyridiner.
DK123589B (da) Fremgangsmåde til fremstilling af 2,3,6-trimethylphenol.
DK120439B (da) Fremgangsmåde til fremstilling af 1,5-disubstituerede 4-cyanopyrazoler.
DK125091B (da) Fremgangsmåde til fremstilling af 1-hydroxy-2-pyridoner.
DK125852B (da) Fremgangsmåde til fremstilling af erythromycylamin.
DK133430B (da) Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-aroylpyrrolidiner.
DK122124B (da) Fremgangsmåde til fremstilling af 2-acyloxythionobenzamider.
DK123232B (da) Analogifremgangsmåde til fremstilling af 3-alkoxy-17α-propinylestra-1,3,5(10)-trien-17β-oler.
DK123236B (da) Fremgangsmåde til fremstilling af 2-alkyl-3-hydoxy-4,5-dihydrofuran-4-oner.
DK123300B (da) Analogifremgangsmåde til fremstilling af thiophen-3-isonitriler.
DK123239B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-4,4-dialkylquinazoliner.
DK121052B (da) Fremgangsmåde til fremstilling af steroid-17α,21-orthocarbonater.
DK125464C (da) Analogifremgangsmåde til fremstilling af 6-halogen-15β, 16β-methylen-pregnanderivater.
DK128008B (da) Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner.
DK122129B (da) Analogifremgangsmåde til fremstilling af N,N'-dialkyl-4-phenylimidazolin-2-thioner.
DK123353B (da) Analogifremgangsmåde til fremstilling af 6,7-methylen-20-spirox-4-en-3-on-forbindelser.
DK126654B (da) Analogifremgangsmåde til fremstilling af 2-hydroxymethyl-3-carboxylsyreamido-quinoxalin-di-N-oxider-(1,4).
DK127812B (da) Analogifremgangsmåde til fremstilling af 3,5-dibrom-zearalan.
DK123818B (da) Fremgangsmåde til fremstilling af 14β-hydroxy-card-20(22)-enolider eller -bufa-20,20-dienolider.
DK122816B (da) Analogifremgangsmåde til fremstilling af 3-aryl-5-methylhydantoiner.
DK124331B (da) Analogifremgangsmåde til fremstilling af 14β-hydroksy-15α-acyloksy-4,20(22)-kardadienolider.
DK121440B (da) Analogifremgangsmåde til fremstilling af 2,4-bis-morpholino- eller-thiomorpholino-5-carbalkoxy-pyrimidiner.
DK140284B (da) Analogifremgangsmåde til fremstilling af oxazinobenzodiazepiner.